A risk score for risk factors: Rationale and roadmap for preventing hypertension

Hypertension

Volumn 54, Issue 3, 2009, Pages 454-456

  Vasan, Ramachandran S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; HEALTH CARE COST; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HIGH RISK POPULATION; HYPERTENSION; INCIDENCE; LIFESTYLE MODIFICATION; MORBIDITY; MORTALITY; NOTE; POPULATION; PRIORITY JOURNAL; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED STATES; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; FAMILY HEALTH; GENETICS; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; PREVALENCE; REPRODUCIBILITY; RISK ASSESSMENT; SMOKING; STATISTICS; UNITED KINGDOM;

BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; FAMILY HEALTH; HUMANS; HYPERTENSION; LONDON; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 70349237188     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.134858     Document Type: Note

References (17)

1. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14: 32-38.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365:217-223.
3. Lawes CM, Vander HS, Rodgers A. Global burden of blood-pressurerelated disease, 2001. Lancet. 2008;371:1513-1518.
4. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2009 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-e181.
5. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058.
6. Evans JG, Rose G. Hypertension. Br Med Bull. 1971;27:37-42.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; for the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
8. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with highnormal blood pressure: the Trials of Hypertension Prevention, Phase II. Arch Intern Med. 1997;157:657-667.
9. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N; for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
10. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin PH; for the DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. N Engl J Med. 2001;344:3-10. (Pubitemid 32064838)
11. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-1697.
12. Kivimäki M, Batty GD, Singh-Manoux A, Ferrie JE, Tabak AG, Jokela M, Marmot MG, Davey Smith G, Shipley MJ. Validating the Framingham hypertension risk score: results from the Whitehall II Study. Hypertension. 2009;54:496-501.
13. Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, D'Agostino RB, Sr., Kannel WB, Vasan RS. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med. 2008;148:102-110.
14. Paynter NP, Cook NR, Everett BM, Sesso HD, Buring JE, Ridker PM. Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med. 2009;122:464-471.
15. Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988;84: 739-749.
16. Strasser T. Reflections on cardiovascular diseases. Interdisc Sci Rev. 1978;3:225-230.
17. National Heart Lung Blood Institute. Report of the Task Force on Research in Epidemiology and Prevention of Cardiovascular Diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1994.